輸入代號或公司名稱後按 Enter
PRGO

PERRIGO Co plc

-0.05 (-0.41%)前一交易日收盤 2026-09-17
美股 · NYSE · 生技醫療 · Pharmaceutical Preparations
13.49USD510K成交股數1.9B市值本益比(近四季)0.5股價營收比-3.2%營收年增(近四季)2026-11-04下次財報

財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束

逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。

營收與利潤率近 16 季

稀釋 EPS近 16 季 · 美元

現金流近 16 季

股東回饋近 16 季 · 庫藏股與股利

損益表 逐季 · 最新在左 · 小字是年增率

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q323Q2
營收1.0B-2%969M-15%1.0B-4%1.1B-1%1.0B-4%1.1B+1%1.1B-9%1.1B-10%1.1B1.1B1.2B1.2B
營業成本709M644M666M693M652M752M683M671M724M713M765M768M
毛利314M-20%326M-16%377M-7%363M-8%392M+10%386M-6%404M-6%395M-5%358M411M428M414M
毛利率30.7%33.6%36.1%34.4%37.6%33.9%37.2%37.0%33.1%36.6%35.9%35.0%
研發費用23.7M24.6M24.9M22.0M26.7M27.8M26.0M29.4M29.0M29.6M32.2M31.1M
銷售管理費用100M115M94.2M113M112M94.6M117M126M130M126M133M135M
營業利益23.5M-50%−372M-426%72.6M-10%45.4M-271%46.9M-185%114M+84%80.4M+42%−26.5M-155%−55.2M62.1M56.8M48.5M
營業利益率2.3%-38.4%7.0%4.3%4.5%10.0%7.4%-2.5%-5.1%5.5%4.8%4.1%
稅後淨利74.5M-1264%−399M+798%7.5M-136%−8.4M-92%−6.4M-420%−44.4M-413%−21.0M-350%−108M+3513%2.0M14.2M8.4M−3.0M
淨利率7.3%-41.1%0.7%-0.8%-0.6%-3.9%-1.9%-10.2%0.2%1.3%0.7%-0.3%
稀釋 EPS0.53-1160%-2.87+797%0.05-133%-0.06-92%-0.05-600%-0.32-420%-0.15-350%-0.79+3850%0.010.100.06-0.02
稀釋股數140M139M139M138M138M137M138M137M138M137M137M135M

資產負債表 期末餘額

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q323Q2
現金與約當現金400M357M432M454M410M559M1.5B543M659M598M555M553M
應收帳款710M697M644M678M717M642M786M726M780M738M754M739M
存貨1.1B1.1B1.2B1.2B1.2B1.1B1.1B1.1B1.1B1.1B1.2B1.2B
總資產7.6B8.0B10.1B10.1B9.8B9.6B11.2B10.4B10.6B10.8B11.0B11.0B
有息負債3.3B3.6B3.6B3.6B3.6B3.6B4.3B3.6B3.6B4.0B4.1B4.1B
總負債5.1B5.5B5.6B5.6B5.4B5.3B6.6B5.9B6.0B6.0B6.1B6.1B
股東權益2.5B2.5B4.4B4.5B4.4B4.3B4.6B4.5B4.7B4.7B4.8B4.8B
負債比66.9%68.7%55.9%55.7%55.3%55.2%59.2%56.3%56.0%56.0%55.8%55.9%
淨現金(現金 − 有息負債)−2.9B−3.3B−3.2B−3.2B−3.2B−3.0B−2.8B−3.1B−3.0B−3.5B−3.5B−3.5B

現金流量表 單季

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q323Q2
營業現金流−114M−64.5M+4507%−1.4M19.4M
資本支出13.8M25.5M25.1M23.2M
自由現金流−127M−90.0M+240%−26.5M−3.8M
折舊攤銷83.3M85.4M86.3M79.9M80.3M82.3M81.9M81.4M88.7M
買回庫藏股
現金股利39.9M40.6M37.6M36.2M
自由現金流率-13.1%-8.6%-2.4%-0.3%

營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度

業務分部2025 年度 · 4.3B
Consumer Self Care Americas2.6B60.8%-4.0%
Consumer Self Care International1.7B39.2%-0.7%
地區2025 年度 · 4.3B
美國2.5B59.1%-4.1%
歐洲1.6B37.6%+0.7%
Other Geographical Areas96.7M2.3%-19.1%
愛爾蘭42.1M1.0%+6.3%
產品/服務2025 年度 · 271M
Contract Manufacturing271M100.0%-11.5%

各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。

年度 10-K

財年營收年增稅後淨利淨利率稀釋 EPS自由現金流
FY20254.3B-2.8%−1.4B-33.5%-10.29145M
FY20244.4B-6.1%−172M-3.9%-1.25245M
FY20234.7B+4.6%−12.7M-0.3%-0.09304M
FY20224.5B+7.6%−141M-3.2%-1.04211M
FY20214.1B+1.2%−68.9M-1.7%-0.524.2M
FY20204.1B+5.6%−163M-4.0%-1.19466M
FY20193.9B-18.2%146M3.8%1.07250M
FY20184.7B131M2.8%0.95490M